Search

Your search keyword '"López-Guillermo, Armando"' showing total 920 results

Search Constraints

Start Over You searched for: Author "López-Guillermo, Armando" Remove constraint Author: "López-Guillermo, Armando"
920 results on '"López-Guillermo, Armando"'

Search Results

1. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target

2. Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

4. Unraveling the genetics of transformed splenic marginal zone lymphoma

5. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

6. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

7. Genetic and phenotypic attributes of splenic marginal zone lymphoma

8. SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

12. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

14. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

15. PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax

16. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era

17. High total metabolic tumor volume at baseline predicts survival independent of response to therapy

19. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

20. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

23. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

25. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy

26. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

27. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

29. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

30. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

31. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

32. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells

33. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma

34. The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma

35. Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure

36. A MALT lymphoma prognostic index

37. High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma

40. Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

41. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

42. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage

43. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

47. Follicular lymphoma

48. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome

49. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

50. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors

Catalog

Books, media, physical & digital resources